Meridian Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Buy |
|
|||||
|
2025
Q1 | $301K | Buy |
|
|||||
|
2024
Q4 | $249K | Buy |
|
|||||
|
2024
Q3 | $281K | Buy |
|
|||||
|
2024
Q2 | $275K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $323K | Buy |
|
|||||
|
2023
Q3 | $265K | Sell |
|
|||||
|
2023
Q2 | $275K | Buy |
|
|||||
|
2023
Q1 | $246K | Sell |
|
|||||
|
2022
Q4 | $234K | Buy |
|
|||||
|
2022
Q3 | $227K | Sell |
|
|||||
|
2022
Q2 | $268K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $784K | Sell |
|
|||||
|
2020
Q3 | $995K | Buy |
|
|||||
|
2020
Q2 | $1.02M | Buy |
|
|||||
|
2020
Q1 | $804K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $257 | Buy |
|